Charles River Laboratories International, Inc. (CRL)
NYSE · Healthcare
Charles River Laboratories International, Inc. Gross Profit 2020–2025
Charles River Laboratories International, Inc. annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Charles River Laboratories International, Inc. gross profit for the quarter ending March 31, 2026 was 294.7 M, a 7.26% decrease year-over-year.
- Charles River Laboratories International, Inc. gross profit for the twelve months ending March 31, 2026 was 1.3 B.
- Charles River Laboratories International, Inc. annual gross profit for 2025 was 1.3 B, a 0.64% decrease from 2024.
- Charles River Laboratories International, Inc. annual gross profit for 2024 was 1.3 B, a 11.36% decrease from 2023.
- Charles River Laboratories International, Inc. annual gross profit for 2023 was 1.5 B, a 2.73% increase from 2022.
- Charles River Laboratories International, Inc. annual gross profit for 2022 was 1.5 B.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Charles River Laboratories International, Inc. Gross Profit — FAQ
Charles River Laboratories International, Inc. (CRL) gross profit over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Charles River Laboratories International, Inc.'s gross profit?
Charles River Laboratories International, Inc. (CRL) reported gross profit of $1.32B for fiscal 2025.
Where can I see CRL's gross profit history?
The chart and table above show Charles River Laboratories International, Inc.'s gross profit by year and by quarter, including the growth rate.